Paul A Friedman
Director at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $26.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 280187,164 held (−0%) | $551.24 | $154K | -14.4% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,480210,204 held (−1%) | $511.98 | $758K | -7.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,094209,110 held (−1%) | $513.11 | $561K | -8.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,345207,765 held (−1%) | $514.68 | $692K | -8.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,996205,769 held (−1%) | $515.81 | $1.0M | -8.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 766205,003 held (−0%) | $516.84 | $396K | -8.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 2,450202,553 held (−1%) | $517.86 | $1.3M | -8.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,363201,190 held (−1%) | $518.68 | $707K | -9.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 846200,344 held (−0%) | $519.88 | $440K | -9.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 681199,663 held (−0%) | $521.03 | $355K | -9.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 840198,823 held (−0%) | $521.98 | $438K | -9.6% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 970197,853 held (−0%) | $523.00 | $507K | -9.8% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,199196,654 held (−1%) | $524.10 | $628K | -10.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 2,432194,222 held (−1%) | $525.05 | $1.3M | -10.2% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,066193,156 held (−1%) | $526.00 | $561K | -10.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,560191,596 held (−1%) | $526.97 | $822K | -10.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 575191,021 held (−0%) | $528.18 | $304K | -10.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 691190,330 held (−0%) | $529.17 | $366K | -10.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 166190,164 held (−0%) | $529.76 | $88K | -11.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 280189,884 held (−0%) | $530.69 | $149K | -11.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 80189,804 held (−0%) | $532.50 | $43K | -11.4% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 332189,472 held (−0%) | $534.16 | $177K | -11.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 148189,324 held (−0%) | $535.29 | $79K | -11.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 473188,851 held (−0%) | $536.02 | $254K | -12.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 487188,364 held (−0%) | $536.88 | $261K | -12.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 80188,284 held (−0%) | $537.85 | $43K | -12.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 480187,804 held (−0%) | $539.23 | $259K | -12.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 600187,204 held (−0%) | $540.36 | $324K | -12.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 40187,164 held (−0%) | $545.79 | $22K | -13.6% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 624211,340 held (−0%) | $547.75 | $342K | -13.9% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 535210,805 held (−0%) | $548.51 | $293K | -14.0% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 409210,396 held (−0%) | $549.99 | $225K | -14.2% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4,316206,080 held (−2%) | $550.93 | $2.4M | -14.4% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 7,193198,887 held (−3%) | $551.67 | $4.0M | -14.5% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 5,533193,354 held (−3%) | $552.74 | $3.1M | -14.7% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 5,001188,353 held (−3%) | $553.83 | $2.8M | -14.8% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,029187,324 held (−1%) | $555.00 | $571K | -15.0% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 160187,164 held (−0%) | $555.39 | $89K | -15.1% |
- Sell
Director Paul A Friedman sold $154K of MDGL at $551.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paul A Friedman sold $758K of MDGL at $511.98 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paul A Friedman sold $561K of MDGL at $513.11 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paul A Friedman sold $692K of MDGL at $514.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paul A Friedman sold $1.0M of MDGL at $515.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paul A Friedman sold $396K of MDGL at $516.84 — pre-scheduled 10b5-1 plan sale.